(Q39990684)

16 September 2017

Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy (English)

1 reference

16 September 2017

0 references

B C Millar

1

1 reference

16 September 2017

J B Bell

series ordinal

2

1 reference

16 September 2017

R L Powles

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

British Journal of Cancer

16 September 2017

1 reference

16 September 2017

73

1 reference

16 September 2017

2

1 reference

16 September 2017

236-240

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.41

16 September 2017

0 references

cites work

Biology of multiple myeloma--host-tumour interactions and immune regulation of disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Immunoregulation of localized and disseminated murine myeloma: antigen-specific regulation of MOPC-315 stem cell proliferation and secretory cell differentiation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

High serum IL-2 levels are predictive of prolonged survival in multiple myeloma.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074310

Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells

20 August 2018

1 reference

12 December 2020

Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha

1 reference

12 December 2020

Imbalances of T-cell subsets in monoclonal gammopathies

1 reference

12 December 2020

Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells

1 reference

12 December 2020

Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status

1 reference

12 December 2020

Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies

1 reference

12 December 2020

A new murine CD4+ T cell subset with an unrestricted cytokine profile

1 reference

12 December 2020

Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies

1 reference

12 December 2020

Natural killer cell activity in monoclonal gammopathies: Relation to disease activity

1 reference

12 December 2020

A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma

1 reference

12 December 2020

Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal Gammopathies

1 reference

12 December 2020

IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones

1 reference

12 December 2020

Intensive combined therapy for previously untreated aggressive myeloma

1 reference

12 December 2020

Increased expression of natural-killer-associated and activation antigens in multiple myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.41

1 reference

16 September 2017

1 reference

16 September 2017

PubMed publication ID

8546912

1 reference